NSE / BSEFinancial Services
β‚Ή86.52-0.38-0.44%
P/E156.0Mkt Capβ‚Ή14.42 K CrEV/EBITDA130.9

NIVA BUPA HEALTH INSURANCE COMPANY LIMITED

P/E156.0Mkt Capβ‚Ή14.42 K CrEV/EBITDA130.9
Company Profile

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
β€”
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
β€”
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–² 4.13% over 1Y
Monthly Returns

Historically, May has averaged the highest return (+11.6%); Oct the lowest (-7.9%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+4.2%Positive MonthJan 2026: +4.24%-4.7%Negative MonthFeb 2026: -4.73%-6.5%Negative MonthMar 2026: -6.48%+11.5%Positive MonthApr 2026: +11.47%+10.0%Positive MonthMay 2026: +9.98%-1.7%Neutral MonthJun 2026: -1.71%+2.4%*Positive MonthJul 2026: +2.40%β€”β€”β€”β€”β€”
2025-3.2%Negative MonthJan 2025: -3.21%-10.0%Negative MonthFeb 2025: -10.03%+6.8%Positive MonthMar 2025: +6.85%+4.4%Positive MonthApr 2025: +4.42%+13.3%Positive MonthMay 2025: +13.28%-11.3%Negative MonthJun 2025: -11.35%+7.0%Positive MonthJul 2025: +7.04%-7.0%Negative MonthAug 2025: -6.99%+0.5%Neutral MonthSep 2025: +0.48%-7.9%Negative MonthOct 2025: -7.86%-1.5%Neutral MonthNov 2025: -1.51%+1.7%Neutral MonthDec 2025: +1.66%
2024β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”+11.3%Positive MonthDec 2024: +11.28%
AvgΒ±SD+0.5%Β±3.7%-7.4%Β±2.7%+0.2%Β±6.7%+7.9%Β±3.5%+11.6%Β±1.7%-6.5%Β±4.8%+4.7%Β±2.3%-7.0%Β±0.0%+0.5%Β±0.0%-7.9%Β±0.0%-1.5%Β±0.0%+6.5%Β±4.8%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 3 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.146x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή5.37 K Crβ–² 30.6%
EBITDA Growthβ€”
Net Profitβ‚Ή214.00 Crβ–² 161.0%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–² 90.2%
Revenue CAGR 5Y31.2%
EBITDA CAGR 5Y0.0%
Net Profit CAGR 5Y0.0%
NP Growth 1Y161.0%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή5.37 K Crβ€”β‚Ή214.00 Crβ€”β€”7.0%30.6%161.0%
Mar 2024β‚Ή4.12 K Crβ€”β‚Ή82.00 Crβ€”β€”4.0%44.2%530.8%
Mar 2023β‚Ή2.85 K Crβ€”β‚Ή13.00 Crβ€”β€”1.6%52.0%-106.6%
Mar 2022β‚Ή1.88 K Crβ€”β‚Ή-197.00β€”β€”-38.9%32.8%294.0%
Mar 2021β‚Ή1.41 K Crβ€”β‚Ή-50.00β€”β€”-8.7%33.7%-19.4%
Mar 2020β‚Ή1.06 K Crβ€”β‚Ή-62.00β€”β€”-17.9%24.2%29.2%
Mar 2019β‚Ή851.00 Crβ€”β‚Ή-48.00β€”β€”-18.3%β€”β€”

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales8511,0571,4131,8772,8534,1155,3745,874
Total Expenses8801,0941,4352,3283,1834,2285,2965,793
EBIT / Operating Profit-29-37-22-451-330-1137881
OPM %-3%-3%-2%-24%-12%-3%1%1%
Other Income00028137422416012
Finance Costs34600000
Depreciation & Amortisation162122273229250
Profit Before Tax-48-62-50-197138221493
Tax %0%0%0%0%0%0%0%-
Net Profit / PAT-48-62-50-197138221493
EPS (β‚Ή)------1.170.51
Dividend Payout %0%0%0%0%0%0%0%-

Peer Comparison

Financials sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
NIVA BUPA HEALTH INSURANCE COMPANY LIMITEDthis co.β‚Ή14.42 K Crβ‚Ή5.37 K Cr156.003.79130.9230.6%
HDFC Bank Ltd.β‚Ή14.43 L Crβ‚Ή3.01 L Cr20.302.78β€”16.3%
ICICI Bank Ltd.β‚Ή10.28 L Crβ‚Ή1.63 L Cr20.703.32β€”14.3%
State Bank Of Indiaβ‚Ή9.49 L Crβ‚Ή4.62 L Cr13.301.83β€”11.4%
Bajaj Finance Limitedβ‚Ή5.91 L Crβ‚Ή61.95 K Cr36.806.33β€”32.0%
LIFE INSURANCE CORPORATION OF INDIAβ‚Ή5.26 L Crβ‚Ή8.87 L Cr10.303.739.875.2%
Kotak Mahindra Bank Ltd.β‚Ή4.24 L Crβ‚Ή52.92 K Cr31.703.39β€”15.5%
Industry Averageβ€”β‚Ή30.80 K Cr45.914.8770.9114.6%

Learn while you research

Hand-picked academy chapters to deepen your understanding of NIVA BUPA HEALTH INSURANCE COMPANY LIMITED and the metrics that matter.

Browse the full Equiscale Academy